B. Braun Medical Inc – FDA 483, Jun 29, 2018
B. Braun Medical Inc. in Irvine, CA, a sterile drug manufacturer, received an FDA Form 483 citing significant deficiencies in laboratory controls and data integrity. Observations included incomplete laboratory records, manipulation of test data, inadequate computer system controls, and a failure to establish proper test method specificity and impurity specifications. These findings indicate serious concerns regarding the reliability of product quality testing and overall data management practices.
ID · f2ded421-4e11-4121-acc6-e2d8ea7d7d5e
- 483 - 2025-11-21
- 483 - 2023-12-15
- 483 - 2020-07-23
- EIR - 2016-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.